This compound is primarily used in the field of medicinal chemistry, particularly in the development of novel therapeutic agents. Its unique structure makes it a potential candidate for targeting specific biological pathways, especially in the treatment of neurological disorders. The compound's ability to interact with certain receptors in the brain suggests its application in the research and development of drugs aimed at modulating neurotransmitter activity. Additionally, its trifluoromethyl groups enhance its stability and bioavailability, making it a promising molecule for further pharmacological studies. Researchers are also exploring its potential use in the treatment of chronic pain and inflammation, given its interaction with specific enzymes and receptors involved in these processes.